Skip links and keyboard navigation

Lung Cancer


+ Emergency

If any of the following are present or suspected, please refer the patient to the emergency department (via ambulance if necessary) or seek emergent medical advice if in a remote region.

Emergency treatment required - needs discussion with on call specialist and/or emergency department.

  • Symptoms of airway obstruction, SVC obstruction
  • Severe gastrointestinal (GI) bleeding
  • Bowel obstruction
  • Febrile neutropenia
  • Symptomatic hypercalcaemia
  • Other organ failure/dysfunction
  • Uncontrolled and disabling pain
  • Massive haemoptysis and/or stridor
  • Neurological signs suggestive of brain metastases or cord compression
  • Very high calcium (3.0mmol/L)
  • Severe dysphagia with dehydration
  • Biopsy proven small cell lung cancer
    • patients with symptoms of shortness of breath, deteriorating organ function
  • Metastatic germ cell tumour (GCT) confirmed (biopsy) or suspected (tumour markers)
  • Patients with severe symptoms, organ failure or life threatening complications
  • Highly aggressive lymphoma
    • Burkitt’s lymphoma
    • lymphoblastic lymphoma
  • Acute leukaemia

+ Useful management information

  • Suspected lung cancers (mass on chest XR or CT chest) needs to be referred to the appropriate specialist (usually respiratory physician) for work-up.  Specialist review optimally should be within 2 weeks
  • Most referrals for locally advanced disease for concurrent chemotherapy and radiation come through respiratory or cardio-thoracic team and after MDT review
  • Suspected spinal cord compression, superior vena cava syndrome (SVC), massive haemoptysis, very high calcium (>3.0mmol/L), febrile neutropenia need to be referred to emergency urgently
  • Lung cancer patients diagnosed and treated via an MDT have improved outcomes
  • For patients with incurable (metastatic or recurrent) cancer, consideration of the following:
    • documentation of discussions with the patient (and their carers where appropriate) regarding the intent of treatment (anti-cancer therapy to improve quality of life and/or longevity without expectation of cure or symptom palliation), the patient’s prognosis and their understanding of their prognosis
    • whether Advance Care Planning (ACP) conversations have been undertaken and their outcome
    • specific patient goals and values that may impact on treatment choices
    • whether the patient has been referred to a palliative or supportive care service
  • Investigating symptoms of lung cancer. A guide for GP’s

  • Optimal care pathway for people with lung cancer

  • Quick reference guide

+ Minimum referral criteria-Does your patient meet the minimum referral criteria?

+ Standard referral information to be included in all referrals

Essential referral information

Without this information the referral will be rejected

GP Essential Referral Information

  • General referral information
  • Past medical history, current medications
  • Smoking history
  • Previous cancer treatment details
  • FBC ELFTs results
  • Any relevant XR results +/- relevant CT reports
    • CT chest, upper abdomen and pelvis
    • If available attach CT or MRI of the brain and bone scan

Specialist Essential Referral Information

  • Include (GP) Essential referral information
  • Tissue pathology +/- cytology results
  • Physiological assessment - pulmonary function test if applicable
  • Bronchoscopy including endobronchial USS (EBUS) if applicable
  • PET scan reports for selected patients

+ Additional referral information for referrals

  • No additional information


Last updated: Monday, August 13, 2018

Send referrals to


Secure messaging:
Secure web transfer IQ43050005G

General Fax:
3810 1438

Priority Fax for urgent category 1 referrals:
3413 7277

Post:
Outpatients Referrals Centre
PO Box 73, Ipswich
Queensland, 4305

Patient Enquiries:
3810 1217

GP/Specialist Referral Enquiry:
3810 1869 or 3810 1858


Named referrals

If you would like to send a named referral, please address it to the specialist on the referral template, who will allocate a suitably qualified specialist to see the patient.

From July 1 2017 Commonwealth growth funding has been capped. This changes how WMHS can fund its growth as an organisation. Named referrals from GP’s help support hospital funding through a Medicare bulk-billing arrangement. The new federal funding model incorporates specific pricing for patients which removes concerns around ‘double dipping'. This benefits hospital and patient services.


Patient must bring

  • Medicare card
  • Any concession cards (e.g. Pension, Health Care, DVA, PBS Safety Net, ADF, etc)